Nature Medicine最新文献

筛选
英文 中文
ChatGPT Health triage advice falls short in key cases. ChatGPT健康分诊建议在关键情况下不足。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-05-07 DOI: 10.1038/s41591-026-04427-1
{"title":"ChatGPT Health triage advice falls short in key cases.","authors":"","doi":"10.1038/s41591-026-04427-1","DOIUrl":"https://doi.org/10.1038/s41591-026-04427-1","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autonomous pathology research using agentic AI shows potential in oncology. 利用人工智能进行自主病理研究在肿瘤学领域显示出潜力。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-05-05 DOI: 10.1038/s41591-026-04403-9
{"title":"Autonomous pathology research using agentic AI shows potential in oncology.","authors":"","doi":"10.1038/s41591-026-04403-9","DOIUrl":"https://doi.org/10.1038/s41591-026-04403-9","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals. 对640万人的prevention和SCORE2心血管风险方程进行跨国验证。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-05-05 DOI: 10.1038/s41591-026-04437-z
Brendon L Neuen, Rupert W Major, Morgan E Grams, Yingying Sang, Josef Coresh, Shoshana H Ballew, Aditya Surapaneni, Natalia Alencar de Pinho, Johan Arnlov, Clare Arnott, Samira Bell, Jarett Berry, Hermann Brenner, Elizabeth Ciemins, Alexander R Chang, Mary Cushman, James A de Lemos, Juan Miguel Diaz-Tocados, Alfredo E Farjat, Robert A Fletcher, Ron T Gansevoort, Hiddo J L Heerspink, William G Herrington, Chuan Hong, Edward J Horwitz, Shih-Jen Hwang, Simerjot K Jassal, Philip A Kalra, Ronit Katz, Sadiya S Khan, Csaba P Kovesdy, Florian Kronenberg, Jennifer S Lees, Donald M Lloyd-Jones, Jose Geraldo Mill, David M J Naimark, Chiadi Ndumele, Kevan R Polkinghorne, Bruce M Psaty, Patrick Schloemer, Michael Shlipak, Prabin Shrestha, Zean Song, Natalie Staplin, Dominik Steubl, Priya Vart, Frank L J Visseren, Mark Woodward, Kazumasa Yamagishi, Bessie A Young, Charumathi Sabanayagam, Jose M Valdivielso
{"title":"Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals.","authors":"Brendon L Neuen, Rupert W Major, Morgan E Grams, Yingying Sang, Josef Coresh, Shoshana H Ballew, Aditya Surapaneni, Natalia Alencar de Pinho, Johan Arnlov, Clare Arnott, Samira Bell, Jarett Berry, Hermann Brenner, Elizabeth Ciemins, Alexander R Chang, Mary Cushman, James A de Lemos, Juan Miguel Diaz-Tocados, Alfredo E Farjat, Robert A Fletcher, Ron T Gansevoort, Hiddo J L Heerspink, William G Herrington, Chuan Hong, Edward J Horwitz, Shih-Jen Hwang, Simerjot K Jassal, Philip A Kalra, Ronit Katz, Sadiya S Khan, Csaba P Kovesdy, Florian Kronenberg, Jennifer S Lees, Donald M Lloyd-Jones, Jose Geraldo Mill, David M J Naimark, Chiadi Ndumele, Kevan R Polkinghorne, Bruce M Psaty, Patrick Schloemer, Michael Shlipak, Prabin Shrestha, Zean Song, Natalie Staplin, Dominik Steubl, Priya Vart, Frank L J Visseren, Mark Woodward, Kazumasa Yamagishi, Bessie A Young, Charumathi Sabanayagam, Jose M Valdivielso","doi":"10.1038/s41591-026-04437-z","DOIUrl":"https://doi.org/10.1038/s41591-026-04437-z","url":null,"abstract":"<p><p>The American Heart Association's PREVENT equations estimate risk of total cardiovascular disease (CVD), atherosclerotic CVD (ASCVD), and heart failure (HF) to guide lipid and blood pressure-lowering therapy in people ages 30 to 79 years in the United States. The SCORE2 risk algorithm is used to estimate CVD risk for similar purposes in people ages 40 and older in Europe. Neither set of equations has been comprehensively validated in global observational cohorts and randomized trials. Here, in 44 observational cohorts and 18 randomized trials, we assessed discrimination and calibration of the two risk algorithms across geographical regions (North America, Europe, Asia/other, multi-region trials). We also created scaling factors for risk prediction over 1-9 years using the PREVENT equations, enabling shorter-term risk prediction for research purposes or to facilitate clinical trial enrolment. Over 5.1 years of mean follow-up, 293,737 PREVENT total CVD events (fatal and non-fatal ASCVD or HF) and 258,086 SCORE2 CVD events (myocardial infarction, stroke, or cardiovascular death) were observed among 6,422,714 and 5,437,384 individuals, respectively. Despite differences in CVD outcome definitions, target populations and predictor variables, overall discrimination and calibration were similar for both equations, with generally good performance across regions, including in multi-regional randomized trials. These findings lend support for adoption of PREVENT or SCORE2 for cardiovascular risk stratification across diverse settings.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial. 作者更正:Benralizumab与安慰剂治疗嗜酸性粒细胞增多综合征:一项随机、安慰剂对照的3期试验。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-05-05 DOI: 10.1038/s41591-026-04425-3
Princess U Ogbogu, Florence Roufosse, Praveen Akuthota, Piotr Kuna, Matthieu Groh, Andreas Reiter, Akira Yokota, Salman H Siddiqui, Pim G N J Mutsaers, Bing Li, Paneez Khoury, Lila M Bahadori, Artur Bednarczyk, Gerben Bouma, Laura G Brooks, Jorge Ferreira, Hanna Grindebacke, Calvin N Ho, Priya Jain, Rebecca L Palmer, Maria L Jison, Amy D Klion
{"title":"Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.","authors":"Princess U Ogbogu, Florence Roufosse, Praveen Akuthota, Piotr Kuna, Matthieu Groh, Andreas Reiter, Akira Yokota, Salman H Siddiqui, Pim G N J Mutsaers, Bing Li, Paneez Khoury, Lila M Bahadori, Artur Bednarczyk, Gerben Bouma, Laura G Brooks, Jorge Ferreira, Hanna Grindebacke, Calvin N Ho, Priya Jain, Rebecca L Palmer, Maria L Jison, Amy D Klion","doi":"10.1038/s41591-026-04425-3","DOIUrl":"https://doi.org/10.1038/s41591-026-04425-3","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An international and independent scientific foundation for AI governance. 国际独立的人工智能治理科学基础。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-05-04 DOI: 10.1038/s41591-026-04375-w
Bilal A Mateen
{"title":"An international and independent scientific foundation for AI governance.","authors":"Bilal A Mateen","doi":"10.1038/s41591-026-04375-w","DOIUrl":"https://doi.org/10.1038/s41591-026-04375-w","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147840273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early kidney risk prediction in APOL1 high-risk genotype carriers. APOL1高危基因型携带者的早期肾脏风险预测
IF 5 1区 医学
Nature Medicine Pub Date : 2026-05-01 DOI: 10.1038/s41591-026-04343-4
{"title":"Early kidney risk prediction in APOL1 high-risk genotype carriers.","authors":"","doi":"10.1038/s41591-026-04343-4","DOIUrl":"https://doi.org/10.1038/s41591-026-04343-4","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147818108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking triage for febrile children in low-resource settings. 重新思考资源匮乏地区发热儿童的分诊方法。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-05-01 DOI: 10.1038/s41591-026-04387-6
Mihir R Atreya, Luregn J Schlapbach
{"title":"Rethinking triage for febrile children in low-resource settings.","authors":"Mihir R Atreya, Luregn J Schlapbach","doi":"10.1038/s41591-026-04387-6","DOIUrl":"https://doi.org/10.1038/s41591-026-04387-6","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147818095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems. 巴西消除艾滋病毒母婴传播:给大规模全球卫生系统的教训。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-05-01 DOI: 10.1038/s41591-026-04373-y
Emilia M Jalil, Valdiléa G Veloso, Beatriz Grinsztejn
{"title":"Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems.","authors":"Emilia M Jalil, Valdiléa G Veloso, Beatriz Grinsztejn","doi":"10.1038/s41591-026-04373-y","DOIUrl":"https://doi.org/10.1038/s41591-026-04373-y","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147817966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
At last, a pipeline for treating kidney disease. 最后,一个治疗肾脏疾病的管道。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-04-30 DOI: 10.1038/d41591-026-00025-3
Carrie Arnold
{"title":"At last, a pipeline for treating kidney disease.","authors":"Carrie Arnold","doi":"10.1038/d41591-026-00025-3","DOIUrl":"10.1038/d41591-026-00025-3","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147817948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A data-driven risk stratification framework for clinical obesity. 数据驱动的临床肥胖风险分层框架。
IF 5 1区 医学
Nature Medicine Pub Date : 2026-04-30 DOI: 10.1038/s41591-026-04370-1
{"title":"A data-driven risk stratification framework for clinical obesity.","authors":"","doi":"10.1038/s41591-026-04370-1","DOIUrl":"https://doi.org/10.1038/s41591-026-04370-1","url":null,"abstract":"","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":" ","pages":""},"PeriodicalIF":50.0,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147817977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书